MetaADEDB 2.0 @ LMMD
Griseofulvin
(DDUHZTYCFQRHIY-RBHXEPJQSA-N)
Structure
SMILES
COC1=CC(=O)C[C@H]([C@@]21Oc1c(C2=O)c(OC)cc(c1Cl)OC)C
Type(s)
Approved; Investigational; Vet_approved
ATC code(s)
D01AA08; D01BA01
Molecular Formula:
C17H17ClO6
Molecular Weight:
352.766
Log P:
2.8103
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
0
TPSA:
71.06
CAS Number(s):
126-07-8; 2884-22-2
Synonym(s)
1.
Griseofulvin
2.
Fulvicin-U-F
3.
Grifulvin V
4.
Gris-PEG
5.
Grisactin
6.
Grisefuline
7.
Fulvicin U F
8.
FulvicinUF
9.
Gris PEG
10.
GrisPEG
External Link(s)
MeSHD006118
PubChem Compound441140
BindingDB31775
ChEBI27779
CHEMBLCHEMBL562
DrugBankDB00400
DrugCentral1331
KEGGcpd:C06686
dr:D00209
Therapeutic Target DatabaseD0C1SF
ZINC622123
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1DizzinessFAERS: 11
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
2HeadacheFAERS: 9
Canada Vigilance: 6
4408278
18378354
CTD
SIDER
Canada Vigilance
US FAERS
3LymphadenopathyFAERS: 7US FAERS
4Stevens-Johnson SyndromeFAERS: 625811541CTD
US FAERS
5FatigueFAERS: 5
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
6Cold sweatFAERS: 3US FAERS
7HepatomegalyFAERS: 315446108CTD
US FAERS
8MalaiseFAERS: 3US FAERS
9NauseaFAERS: 3
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
10ProteinuriaFAERS: 3SIDER
US FAERS
11PruritusFAERS: 3
Canada Vigilance: 4
Canada Vigilance
US FAERS
12SplenomegalyFAERS: 3US FAERS
13SwellingFAERS: 3US FAERS
14Activities of daily living impairedFAERS: 2US FAERS
15AgitationFAERS: 2US FAERS
16ArthralgiaFAERS: 2US FAERS
17ChillsFAERS: 2US FAERS
18Feeling abnormalFAERS: 2SIDER
US FAERS
19LeukopeniaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
20Memory impairmentFAERS: 2US FAERS
21MyalgiaFAERS: 2US FAERS
22PainFAERS: 2US FAERS
23Rash erythematousFAERS: 2
Canada Vigilance: 3
Canada Vigilance
US FAERS
24VomitingFAERS: 2SIDER
US FAERS
25Abdominal discomfortFAERS: 1US FAERS
26Acute kidney injuryFAERS: 1US FAERS
27Alanine Aminotransferase IncreasedFAERS: 1US FAERS
28AmnesiaFAERS: 1US FAERS
29AnorexiaFAERS: 1US FAERS
30ArthritisFAERS: 1US FAERS
31Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
32Blood creatinine increasedFAERS: 1US FAERS
33Blood pressure orthostatic abnormalFAERS: 1US FAERS
34Burning sensationFAERS: 1US FAERS
35CandidiasisFAERS: 1US FAERS
36CheilitisFAERS: 1US FAERS
37Chest PainFAERS: 1US FAERS
38Chest discomfortFAERS: 1US FAERS
39Complement factor C3 decreasedFAERS: 1US FAERS
40Complement factor C4 decreasedFAERS: 1US FAERS
41Congenital hearing disorderFAERS: 1US FAERS
42ConjunctivitisFAERS: 1US FAERS
43DehydrationFAERS: 1US FAERS
44DermatomyositisFAERS: 1US FAERS
45Developmental Coordination DisorderFAERS: 1US FAERS
46Drug exposure during pregnancyFAERS: 1US FAERS
47Drug ineffectiveFAERS: 1US FAERS
48EcchymosisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
49EczemaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
50EnuresisFAERS: 1US FAERS
51Epidermal necrosisFAERS: 1US FAERS
52Exfoliative rashFAERS: 1US FAERS
53FlatulenceFAERS: 1US FAERS
54General physical health deteriorationFAERS: 1US FAERS
55Genital erosionFAERS: 1US FAERS
56HypersensitivityFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
57Inappropriate schedule of drug administrationFAERS: 1US FAERS
58Irritable Bowel SyndromeFAERS: 1US FAERS
59Joint swellingFAERS: 1US FAERS
60Lip swellingFAERS: 1US FAERS
61LymphocytosisFAERS: 1US FAERS
62Medication ErrorFAERS: 1US FAERS
63Mental status changesFAERS: 1US FAERS
64Microsporum infectionFAERS: 1US FAERS
65OverdoseFAERS: 1US FAERS
66PallorFAERS: 1US FAERS
67PancytopeniaFAERS: 1US FAERS
68Perivascular dermatitisFAERS: 1US FAERS
69Personality ChangeFAERS: 1US FAERS
70Product storage errorFAERS: 1US FAERS
71PsoriasisFAERS: 1US FAERS
72PurpuraFAERS: 1US FAERS
73ScreamingFAERS: 1US FAERS
74Serum SicknessFAERS: 1US FAERS
75TremorFAERS: 1US FAERS
76TrichophytosisFAERS: 1US FAERS
77Unresponsive to stimuliFAERS: 1US FAERS
78Urinary IncontinenceFAERS: 1US FAERS
79Urine bilirubin increasedFAERS: 1US FAERS
80Abdominal PainCanada Vigilance: 1Canada Vigilance
81AgranulocytosisSIDER
82Anemia2237566CTD
83AngioedemaSIDER
84AstheniaSIDER
85Back PainCanada Vigilance: 1Canada Vigilance
86Chemical and Drug Induced Liver Injury

View details

CTD
87Cholestasis

View details

CTD
88Depressive disorder19043281CTD
89DermatitisSIDER
90Dermatomycoses1967699CTD
91Disseminated Intravascular Coagulation2084866CTD
92DyspepsiaSIDER
93Encephalitis2084866CTD
94Epigastric distressSIDER
95Epilepsy595848CTD
96Erythema MultiformeSIDER
97ErythemaCanada Vigilance: 2Canada Vigilance
SIDER
98Fever18378354CTD
99Hematuria2237566CTD
100Hepatitis15446108CTD
SIDER
101Inflammation12735108CTD
102Jaundice, Obstructive131731CTD
103Kidney Diseases8323253CTD
104LethargyCanada Vigilance: 1Canada Vigilance
105Liver Cirrhosis12735108CTD
106Liver Neoplasms, Experimental7214331
11746257
CTD
107Liver neoplasms698038
2445643
CTD
108Lupus Erythematosus, Systemic7577414CTD
109Mucocutaneous Lymph Node Syndrome8403486CTD
110Musculoskeletal stiffnessCanada Vigilance: 1Canada Vigilance
111Mycoses1751019
4424881
CTD
112Myositis7572547CTD
113Nasopharyngitis18378354CTD
114Nephritis, Interstitial2237566CTD
115NephrosisSIDER
116Nephrotic Syndrome7577414CTD
SIDER
117NeuropathySIDER
118NeutropeniaCanada Vigilance: 1Canada Vigilance
119Onychomycosis8985273CTD
120Oral candidiasisSIDER
121PalpitationsCanada Vigilance: 1Canada Vigilance
122Paresthesia1967699CTD
123Porphyrias, Hepatic1751019
6679936
19043281
CTD
124Protein urine presentSIDER
125Psychoses, Substance-Induced4408278CTD
126Pyuria2237566CTD
127Raynaud Disease5414890CTD
128Renal Insufficiency2237566CTD
129SomnolenceCanada Vigilance: 1Canada Vigilance
130ThrombocytopeniaCanada Vigilance: 1Canada Vigilance
131Tinea Capitis18378354CTD
132Tinea Pedis8145958CTD
133Tinea698038
11558553
CTD
134UrticariaCanada Vigilance: 8Canada Vigilance
SIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.